Oct 8 (Reuters) - Stem Cell Therapeutics Corp:
* Receives FDA end of phase II meeting date
* Says date has been set for December 20, 2010
* Sees meeting will focus on a review of the positive safety data generated
to-date
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223
8780))